Simpo, Florencia M.
HRN: 22-59-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/18/2023
02/25/2023
IV
2.25g
Q6hrs As Iv Infusion
T/C Aspiration Pneumonka
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes